
Conference Coverage
Latest Content

MASH Care Demands More Than New Drugs: Meena Bansal, MD

DD01, Pemvidutide Data Suggest Dual Agonists Target MASH Directly: Mazen Nourredin, MD

Phase 3 Data Highlight Hair Regrowth With Deuruxolitinib in AA

Bepirovirsen Achieves Clinically Meaningful Functional Cure Rates in Chronic Hepatitis B

Reducing GLP-1 Prior Authorization Friction: A Managed Care Playbook

Shorts










Podcasts
Center on Health Equity & Access
All News

Ohio cancer care leaders identified persistent gaps in quality, pharmacy infrastructure, bispecific access, and biomarker testing at a May 2026 summit.

Two posters presented at the EASL Congress 2026 highlight promising clinical and preclinical findings for AHB-137.

Despite high US health care spending, data show lower life expectancy, worse maternal mortality, and too few primary care doctors.

ACS updated CRC screening guidelines, adding blood-based and stool tests to expand screening access and improve early detection.


Medicare FFS beneficiaries with metastatic cancer received broad genomic profiling more often than MA patients.

The Ugandan MInistry of Health closed their border with the DRC in response to the rise in Bundibugyo cases and deaths.

Data from the STEPIn trial shows early intervention for plaque psoriasis with secukinumab delivers durable disease control, with some staying clear up to a year post treatment.

The American Thoracic Society 2026 International Conference included sessions that focused on topics such as pulmonary rehabilitation and global disparities in thoracic care.

New Jersey, Where Cancer Care Choice Abounds, Puts Patients at the Center
An Institute for Value-Based Medicine® event in Princeton highlights how the state's leading cancer care providers meet the needs of a diverse population.






















